It Takes a Village: Treating Patients for NSCLC Brain Mets It Takes a Village: Treating Patients for NSCLC Brain Mets
Treatment decisions for patients with NSCLC metastasized to the brain should involve a multidisciplinary team, considering factors such as immunotherapy efficacy and optimal treatment sequences.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
MEGA CRISPR: Engineering Better Immunotherapies with RNA Editing
Multi-targeted Cas13 screens help researchers avoid permanent DNA cuts and evade T cell exhaustion. (Source: The Scientist)
Source: The Scientist - April 1, 2024 Category: Science Tags: News News & Opinion Source Type: news
' Quad Shot' RT, Immunotherapy Improves Local Control in HNC'Quad Shot' RT, Immunotherapy Improves Local Control in HNC
A palliative Quad Shot radiotherapy regimen alongside concurrent immunotherapy can improve local control in symptomatic patients with head and neck cancer but may not improve overall survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Mayo Clinic scientists pioneer immunotherapy technique for autoimmune diseases
Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases.
The new technique, detailed in a preclinical study published in Nature Biomedical Engineering, involves combining chimeric antigen receptors (CAR) with mesenchymal stromal cells (MSC), resulting in engineered stem cells known as CAR-MSCs. (Source: World Pharma News)
Source: World Pharma News - April 1, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Mayo Clinic scientists pioneer immunotherapy technique for autoimmune diseases
Mesenchymal stromal cell ROCHESTER, Minn. — Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases. The new technique, detailed in a preclinical study published in Nature Biomedical Engineering, involves combining chimeric antigen receptors (CAR) with mesenchymal stromal cells (MSC), resulting in engineered stem cells known as CAR-MSCs. “The pioneering approach shows potential in targeting inflammatory disease sites more precisely and improving immunosuppression and healing… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 1, 2024 Category: Databases & Libraries Source Type: news
Doctor Gets First U.S. Lung-Liver Transplant for Advanced Lung Cancer
THURSDAY, March 28, 2024 -- Dr. Gary Gibbon didn’t have long to live.
A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently destroyed his lungs and caused irreparable damage to his... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 28, 2024 Category: General Medicine Source Type: news
Promising First-In-Human Phase 1B Clinical Study Data from VRON-0200, a Novel, First-in-Class Checkpoint Modifier Immunotherapy for Chronic Hepatitis B Virus Functional Cure, Presented as Late-Breaker at 2024 APASL Global Liver Meeting
Highlights from the Data Presentation Initial safety data presented on the first 10 chronically HBV-infected patients representing 674 patient days of treatment VRON-0200 was well tolerated, with no serious adverse events (SAEs) observed: no patients discontinued treatment one treatment... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 28, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Why So Many Dogs Have Allergies Now
Every day, itchy dogs shuffle into Elizabeth Falk’s veterinary office. Some can’t stop chewing their feet or scratching their bellies. Others have red, smelly ears, or rashes on their skin. All are intensely uncomfortable because of environmental allergies. “They’re sitting in the waiting room, and everyone else is backing away out of fear that it’s contagious,” she says. “It’s super busy helping as many as we can.” Until recently, Falk was a veterinary dermatologist at Cornell University Veterinary Specialists, where she saw about 15 allergic pets a day and was booked ...
Source: TIME: Health - March 27, 2024 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized healthscienceclimate Source Type: news
Subcutaneous Immunotherapy: Better Life for Cancer Patients Subcutaneous Immunotherapy: Better Life for Cancer Patients
Administering immunotherapy via subcutaneous infections could save clinicians time and money and patients may prefer it.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 26, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
PHILADELPHIA, March 21, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced its upcoming presentations at the American... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 21, 2024 Category: Pharmaceuticals Tags: CCA FVT Source Type: news
Bypassing Oral Immunotherapy Buildup Safe in Children With Food Allergy
THURSDAY, March 21, 2024 -- An initial phase of multifood sublingual immunotherapy (SLIT) that bypasses oral immunotherapy (OIT) buildup is safe and effective, according to a study published online Feb. 27 in the Journal of Allergy and Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2024 Category: Pharmaceuticals Source Type: news
Remarkable Patients Inspired Father of Cancer Immunotherapy Remarkable Patients Inspired Father of Cancer Immunotherapy
The father of cancer immunotherapy, Steven A. Rosenberg, reflects on the patients who inspired his groundbreaking research.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Breast cancer drug may help thousands more women than previously thought
Pembrolizumab is used to treat triple-negative form of disease but researchers say it could be used more widelyThousands more women with breast cancer could benefit from a blockbuster immunotherapy drug than previously thought, research suggests.Pembrolizumab, sold under the brand name Keytruda, targets and blocks a specific protein on the surface of certain immune cells that then seek out and destroy the cancerous cells.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 19, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Breast cancer UK news Women Health Science NHS Source Type: news
AHN, Baylor Scott & amp; White, and Johns Hopkins researchers confirm effectiveness of new immunotherapy drug combination for gastroesophageal cancer treatment
'Nature Medicine' study, published this week, shows immune checkpoint inhibitor drug therapy, followed by traditional cancer treatment and tumor removal, improved patient survival rates for one of the world's deadliest cancers PITTSBURGH, March 19, 2024 /PRNewswire-PRWeb/ -- Researchers... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Why a New Inhalable Lung Cancer Treatment Is So Promising Why a New Inhalable Lung Cancer Treatment Is So Promising
Study showed that exosomes (tiny spheres released by cells) can deliver potent immunotherapy to lung cancer tumors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
